mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.2 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |